CHORUS Clean Energy AG

  • WKN: A12UL5
  • ISIN: DE000A12UL56
  • Land: Deutschland

Nachricht vom 11.01.2017 | 16:06

CHORUS Clean Energy AG: Preliminary announcement of the publication of financial reports according to Articles 37v, 37w, 37y of the WpHG [the German Securities Act]

CHORUS Clean Energy AG / Preliminary announcement on the disclosure of
financial statements

11.01.2017 / 16:06
Preliminary announcement of the publication of financial reports according
to Articles 37v, 37w, 37y of the WpHG [the German Securities Act]
transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


CHORUS Clean Energy AG hereby announces that the following financial reports shall be disclosed : Report: Annual financial report of the group Date of disclosure / German: March 31, 2017 Date of disclosure / English: March 31, 2017 German: http://www.chorus.de/investor-relations/publikationen/ English: http://www.chorus.de/en/investor-relations/publications/ Report: Financial report of the group (half-year/Q2) Date of disclosure / German: August 31, 2017 Date of disclosure / English: August 31, 2017 German: http://www.chorus.de/investor-relations/publikationen/ English: http://www.chorus.de/en/investor-relations/publications/
11.01.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language: English Company: CHORUS Clean Energy AG Prof.-Messerschmitt-Straße 3 85579 Neubiberg / Munich Germany Internet: www.chorus-gruppe.de End of News DGAP News Service

GBC im Fokus

Ergomed PLC: Kursziel angehoben

Die erfolgreiche Wirksamkeitsstudie von Lorediplon zeigt, dass Ergomed PLC eine sehr vielversprechende Co-Development-Pipeline hat. Eine mögliche vorzeitige Auslizenzierungen des Produkts würde dem Unternehmen signifikante Erfolgsbeteiligungen sichern. Deshalb und aufgrund der Anpassung der Wechselkurse erhöhen wir den fairen Wert der Ergomed-Aktie auf 3,41 € je Aktie. Das Rating bleibt KAUFEN.

Aktueller Webcast

Elmos Semiconductor AG

Analysts' Conference Call FY 2016

15. Februar 2017

Aktuelle Research-Studie

Ergomed plc

Original-Research: Ergomed plc (von GBC AG): Kaufen

21. Februar 2017